Acacia Research News

CombiMatrix Corporation held a web-broadcast on October 7, 2008 to discuss its development of a Comprehensive Cancer Array test for the non-invasive screening of multiple cancers simultaneously.

CombiMatrix Corporation will hold a conference call to discuss the development of its CombiMatrix Cancer Array test for cancer screening.

Leuchemix Corporation announced that permission to undertake clinical safety trials of its drug LC-1, for leukemia, has been granted and that the sponsored trial will begin shortly.

CombiMatrix Corporation has been named to Deloitte's prestigious Technology Fast 50 program for Washington State, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences ...

"Acacia continues to grow its base of future revenues by adding new patent portfolios," commented Paul Ryan, Acacia Chairman and CEO.

CombiMatrix Corporation will hold a conference call to discuss recent findings demonstrating the value of its HemeScan test for Leukemia patients.

MUKILTEO, Wash., Aug. 13, 2008 -- CombiMatrix Corporation today reported its financial results for the three and six months ended June 30, 2008.

CombiMatrix Corporation announced today that it will release its second quarter financial results on Wednesday, August 13, 2008.

Karl Maurer , ‡ and Kevin D. Moeller *† Department of Chemistry, Washington University, St.

July 28, 2008 Contacts Synchronization Corp., a subsidiary of Acacia Research Corp.

Acacia Research Corporation today reported results for the three months ended June 30, 2008.

Karl Maurer , ‡ and Kevin D. Moeller *† Department of Chemistry, Campus Box 1134, Washington University, St.

CombiMatrix Corporation announced today that it has launched an updated version of its ATScan test for pre-disposition screening for autism, through its wholly owned subsidiary CombiMatrix Molecular Diagnostics ...

Acacia Subsidiary Enters into a Settlement and License Agreement with BenQ America Corp.

CombiMatrix Corporation announced today that it has received a new contract from the U.S. Department of Defense to continue development of products and technologies for military use.

CombiMatrix Corporation announced today that it has sold a $10 million secured convertible note to a single institutional investor.

CombiMatrix Corporation will join the Russell Microcap Index when Russell Investments reconstitutes its family of U.S. indexes on June 27, according to a preliminary list of additions posted on www.russell.com ...

NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation announced today that its subsidiary, Acacia Patent Acquisition LLC, has acquired rights to a patent relating to Internet radio advertisement ...

Last week, Peter Detkin, founder and Vice-Chairman of Intellectual Ventures was quoted as saying that small inventors only received the "crumbs" when it came to patent licensing revenue. via Peter Zura's Two-Seventy-One Patent Blog

“With this transformative product, we continue to demonstrate our innovative capabilities and strategy, and meet our goal of at least one array based diagnostic product launch per quarter”

CombiMatrix Corporation announced today that its subsidiary, Combimatrix Molecular Diagnostics, Inc. via PrimeNewswire